🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking Union Medical College Hospital276 Beijing Tiantan Hospital214 Cancer Institute and Hospital, Chinese Academy of Medical Sciences197 AstraZeneca183 Peking University People's Hospital158
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Beijing

5484 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HRS-3802 Monotherapy in Patients With Malignant Solid Tumors
NCT06770569Advanced Solid Tumors
Shandong Suncadia Medicine Co., Ltd.
Phase 1
100
Beijing
2025-01-21
By invitation
ARTLifeLine: Assisted Reproduction Technology (ART) Family Health and Development Trajectory Cohort (ARTLL)
NCT06786871Reproductive Techniques, Assisted, Family, Cohort Studies, Development, Infant
Peking University Third Hospital
Observational
100,000
Beijing
2025-01-20
Active, closed
A Phase I Clinical Study of VSA012 in Healthy Volunteers
NCT06766929Healthy Volunteers
DrugVSA012
Bisirna Therapeutics (Suzhou) Co., Ltd.
Phase 1
40
Beijing
2025-01-20
Recruiting
CAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and Lymphoma
NCT06834529Relapsed or Refractory B Cell Leukemia and Lymphoma
Affiliated Hospital to Academy of Military Medical Sciences
Phase 1/2
20
Beijing
2025-01-20
Recruiting
A Pilot Trial of Pressure Muscle Index-Targeted PSV Trial
NCT06769360Critical Care, Acute Hypoxic Respiratory Failure, Ventilator Lung
Capital Medical University
Not applicable
60
Beijing
2025-01-20
Recruiting
Efficacy and Safety of Remimazolam Besylate for Sedation in Post-Non-Cardiac Surgery Patients Requiring Mechanical Ventilation
NCT06575530Effect of Drug, Adverse Drug Event, Mechanical Ventilation Complication, Critical Illness
DrugRemimazolam Besylate
Beijing Shijitan Hospital, Capital Medical University
Phase 4
306
Beijing
2025-01-20
Recruiting
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
NCT06568939Non-Small Cell Lung Cancer
DrugTelisotuzumab vedotin
AbbVie
Phase 2
150
Beijing, Fuzhou, Nanning, Harbin, Zhengzhou, Wuhan, Nanchang, Xi'an
2025-01-20
Active, closed
A Observational Study to Evaluate Deucravacitinib in Patients With Moderate Plaque Psoriasis in China
NCT06512337Plaque Psoriasis
DrugDeucravacitinib
Bristol-Myers Squibb
Observational
153
Guangzhou, Handan, Dalian, Shanghai, Beijing
2025-01-20
Recruiting
Comparative Study of SMILE, ICL, and Wavelight Plus Alcon Technologies in Myopia Correction
NCT06788418Myopia
Beijing Visionly Plus Eye Hospital
Not applicable
1,000
Beijing
2025-01-20
Active, closed
Evaluation of the Efficacy and Safety of Microwave Ablation of Uterine Adenomyosis Under Improved Ultrasound Guidance
NCT06751264Adenomyosis of Uterus
Peking University Aerospace Center Hospital
Not applicable
137
Beijing
2025-01-20
By invitation
A Multicenter Prospective Cohort Study of Adjuvant Therapy for BRCA1/2 Mutated Hormone Receptor-positive HER2-negative Early High-risk Breast Cancer
NCT06791161Breast
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
300
Beijing
2025-01-19
Recruiting
Evaluating Modulation Effects of Burst Stimulation Patterns Using SEEG
NCT06667232Epilepsy
Xuanwu Hospital, Beijing
Not applicable
20
Beijing
2025-01-18
Recruiting
Clinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell Leukemia
NCT06890494Leukemia
Beijing GoBroad Hospital
Phase EARLY_PHASE1
3
Beijing
2025-01-18
Recruiting
PCCT-Defined High-Risk Plaque and Future Coronary Events: The PREDICT Study
NCT07822737Coronary Artery Disease, Plaque, Photon-Counting Computed Tomography
Beijing Chao Yang Hospital
Observational
500
Beijing
2025-01-18
Active, closed
Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute Graft-versus-Host Disease
NCT07576010Acute Graft-versus-host Disease
Daihong Liu
Phase 1
30
Beijing
2025-01-17
Recruiting
Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ
NCT06761846Gastric Adenocarcinoma, Esophagogastric Junction Adenocarcinoma
DrugSintilimab
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
70
Beijing
2025-01-17
Active, closed
Effect of CGM on Glucose Control in Non-insulin-treated Patients With Type 2 Diabetes Mellitus
NCT06587438Diabetes Mellitus
Sinocare
Not applicable
160
Beijing, Chongqing, Shunde, Wuhan, Jinan, Shanghai
2025-01-17
Recruiting
HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours
NCT06708663Biliary Tract Cancer, Melanoma
DrugIN10018
Hangzhou Hanx Biopharmaceuticals, Ltd.
Phase 1/2
124
Beijing
2025-01-17
Recruiting
A Study of AK129 With or Without AK117 in PD(L)1-refractory Classic Hodgkin Lymphoma
NCT06642792Classic Hodgkin Lymphoma
Akeso
Phase 1/2
280
Beijing
2025-01-17
Recruiting
Different Cycles of Neoadjuvant PD-1 Blockades + Chemotherapy for Advanced Gastric Cancer
NCT06798376Gastric Adenocarcinoma
Chinese PLA General Hospital
Observational
300
Beijing
2025-01-16
Active, closed
Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD
NCT06724809NMOSD, Neuromyelitis Optica Spectrum Disorders
DrugEculizumab
Alexion Pharmaceuticals, Inc.
Phase 3
21
Beijing, Dongguan, Jinan, Shanghai, Taiyuan, Wenzhou, Wuhan
2025-01-16
Active, closed
A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects With Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise
NCT06777238Type 2 Diabetes Mellitus (T2DM)
Gan & Lee Pharmaceuticals.
Phase 3
274
Beijing
2025-01-16
By invitation
Minimally Invasive Soft Channel Brain Haemorrhage Evacuation for Acute Basal Ganglia Haemorrhage--Small Hemorrhage Evacuation (MIRACLE-S)
NCT06688162Intracerebral Hemorrhage
Capital Medical University
Not applicable
750
Beijing
2025-01-16
Recruiting
Intracardiac Echocardiography-Guided Cavotricuspid Isthmus Ablation With a Circular-Shaped Pulsed Field Ablation Catheter
NCT07353775Atrial Fibrillation (AF), Atrial Flutter
Beijing Anzhen Hospital
Observational
150
Beijing
2025-01-15
Not yet open
Conservative Treatment for Atlantoaxial Dislocation Patients Without Neurological Deficit
NCT06772311Atlantoaxial Dislocation
Peking University Third Hospital
Observational
300
Beijing
2025-01-15
Not yet open
Adjuvant Treatment of ALK-positive Non-small Cell Lung Cancer with Ensartinib Guided by MRD
NCT06780839NSCLC, Stage I, II, IIIA, IIIB
Peking University Cancer Hospital & Institute
Phase 2
70
Beijing
2025-01-15
Active, closed
Artificial Intelligence-assisted Diagnosis
NCT06783933Congenital Heart Disease (CHD), Structural Heart Disease
China National Center for Cardiovascular Diseases
Observational
60,000
Beijing
2025-01-15
Recruiting
A Study of XS-04 in Patients with Relapsed or Refractory Hematologic Malignancies
NCT06820268B-cell Lymphoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome
NovaOnco Therapeutics Co., Ltd.
Phase 1
168
Beijing, Guangdong, Hebei, Hubei
2025-01-14
Recruiting
Correlation Analysis of POD and pNCD in Elderly Spinal Surgery Patients
NCT06466083Postoperative Delirium, Postoperative Neurocognitive Disorder, Spinal Surgery
Xuanwu Hospital, Beijing
Observational
165
Beijing
2025-01-14
Recruiting
Evaluate the Efficacy and Safety of TTYP01 Tablets in Adolescents and Children With ASD
NCT06757504Autism Spectrum Disorder (ASD)
Shanghai Auzone Biological Technology Co., Ltd.
Phase 2
150
Beijing, Changsha, Chengdu, Nanjing, Tianjin
2025-01-13
Not yet open
MxA and CRP-Guided Use of Antimicrobial Agents for AECOPD
NCT06779344Acute Exacerbation Chronic Obstructive Pulmonary Disease
Capital Medical University
Not applicable
458
Beijing
2025-01-13
Recruiting
A Study of the Efficacy and Safety of WXSH0102 in Treating VCC Patients
NCT06771063Vaginitis
Cisen Pharmaceutical CO., LTD.
Phase 2
108
Beijing
2025-01-13
Recruiting
Pre-emptive Scalp Infiltration with Triamcinolone Acetonide Plus Ropivacaine for Post-Craniotomy Pain in Children
NCT06779396Pain, Postoperative Children
Beijing Tiantan Hospital
Phase 4
128
Beijing
2025-01-10
Recruiting
IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors
NCT06349408Locally Advanced Solid Tumor
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
250
Beijing, Shanghai, Hangzhou
2025-01-10
Recruiting
An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors
NCT06589596Advanced Solid Tumor
BeOne Medicines
Phase 1
525
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Meizhou, Nanning
2025-01-10
By invitation
Prospective, Multicentre, Randomized, Blind, Parallel-controlled Clinical Trial Evaluating the Efficacy and Safety of Recombinant Collagen Gel for Correcting Moderate to Severe Nasolabial Wrinkles
NCT06854796Nasolabial Fold Wrinkles
Shaanxi Giant Biotechnology Co., Ltd
Not applicable
244
Beijing
2025-01-10
Recruiting
A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer
NCT07673029HER2-positive Breast Cancer
DrugTrastuzumab emtansine
GeneQuantum Healthcare (Suzhou) Co., Ltd.
Phase 3
228
Bengbu, Fuyang, Hefei, Beijing, Chongqing, Fuzhou, Quanzhou, Guangzhou
2025-01-10
Recruiting
A Safety and Tolerability Study of BPR-30221616 Injection in Healthy Subjects
NCT06760455Healthy Participants
Chengdu Brilliant Pharmaceutical Co., Ltd.
Phase 1
48
Beijing
2025-01-10
Recruiting
Comparative Study on the Effect of Diet Interventions on Weight Loss in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment
NCT07318727Endometrium Cancer
Peking University People's Hospital
Not applicable
81
Beijing
2025-01-10
Active, closed
Performance Evaluation of Artificial Intelligence Screening Model in Coronary Heart Disease Detection
NCT06658600Coronary Heart Disease
Tsinghua University
Not applicable
900
Beijing, Shanghai
2025-01-10
Recruiting
Assessment of Senl_B19 CAR-T Cells in Relapsed/Refractory CD19+ B-ALL
NCT07244406B-ALL
Hebei Senlang Biotechnology Inc., Ltd.
Phase 2
59
Beijing
2025-01-10
Not yet open
Population Pharmacokinetics of L-AmB in Chinese Patients Assisted by Extracorporeal Membrane Pulmonary Oxygenation (ECMO)
NCT06754436Invasive Fungal Infections, Liposomal Amphotericin B
Beijing Anzhen Hospital
Phase 4
30
Beijing
2025-01-10
Not yet open
Intra-arterial Hypothermic Magnesium Sulfate Infusion in Combination with Endovascular Thrombectomy in Acute Ischemic Stroke
NCT06760195Acute Ischemic Stroke
DrugThrombolysis
Capital Medical University
Phase EARLY_PHASE1
6
Beijing
2025-01-10
Active, closed
A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer
NCT07005336Non Small Cell Lung Cancer
DrugsUliledlimab·Sintilimab·Gemcitabine·Pemetrexed
TJ Biopharma Co., Ltd.
Phase 2
150
Beijing, Binzhou, Chengdu, Chongqing, Ha’erbin, Hefei, Jiangmen, Kunming
2025-01-09
Recruiting
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
NCT06807424Arthritis, Psoriatic
DrugIcotrokinra
Janssen Research & Development, LLC
Phase 3
750
Beijing, Changchun, Changsha, Chengdu, Chongqing, Dongguan, Guangzhou, Guiyang
2025-01-09
Active, closed
Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy
NCT06711523Neutropenia, Chemotherapy-Induced Febrile, Breast Neoplasm Female
Kexing Biopharm Co., Ltd.
Phase 3
250
Beijing
2025-01-09
Active, closed
Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII Products
NCT06738485Congenital Hemophilia A
CSL Behring
Phase 3
60
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Liuzhou, Tangshan, Tianjin
2025-01-09
Recruiting
AI Model for Assessing Cardiac Surgeons' Techniques
NCT06739005CABG-patients, CABG, Cardiovascular Surgery, Surgeons
China National Center for Cardiovascular Diseases
Observational
284
Beijing
2025-01-09
By invitation
The Application of Novel Identified CD8 Regulatory Precursors in Inducing Immune Tolerance After Allo-HSCT
NCT06864598Graft-versus-host Disease (GVHD)
Peking University People's Hospital
Observational
100
Beijing
2025-01-09
Recruiting
Effect of Lactobacillus DSM17938+ on Functional Constipation and Intestinal Flora in Pregnant Women
NCT06802042Functional Constipation (FC)
Peking Union Medical College Hospital
Not applicable
40
Beijing, Wenzhou
2025-01-09
Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy With GenSci122 in Participants With Advanced Solid Tumors
NCT06772415Advanced Solid Tumor
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
163
Beijing, Zhengzhou, Changsha, Nanjing, Jinan, Shanghai, Tianjin
2025-01-08
Recruiting
A Phase 2 Study of HX301 in Patients with High-grade Giloma
NCT06703255Glioma
DrugTemozolomide
Hangzhou Hanx Biopharmaceuticals, Ltd.
Phase 1/2
72
Beijing
2025-01-08
Recruiting
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
NCT06712316Non-small Cell Lung Cancer
DrugsPumitamig·Pemetrexed·Carboplatin·Pembrolizumab
BioNTech SE
Phase 2/3
1,580
Baoding, Beijing, Changchun, Hangzhou, Jinan, Kunming, Nanjing, Shanghai
2025-01-07
Recruiting
Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia
NCT06722586Antiphospholipid (aPL)-Positive, Thrombocytopaenia
DrugsRapamycin·Paclitaxel
Peking University First Hospital
Phase 4
84
Changsha, Jinan, Chengdu, Ürümqi, Wenzhou, Beijing, Shanghai
2025-01-07
Recruiting
Assessment of Adebelizumab Combined With Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
NCT06768307SCLC, Extensive Stage, Immunotherapy, Chemotherapy, Radiotherapy
Peking University Cancer Hospital & Institute
Phase 2
60
Beijing
2025-01-07
Recruiting
Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT06792253Relapsed/Refractory Diffuse Large B-Cell Lymphoma
DrugsIfupinostat Hydrochloride·Ifosfamide·Gemcitabine Hydrochloride·Etoposide
BeBetter Med Inc
Phase 3
416
Beijing
2025-01-06
Recruiting
High-frequency SCS Versus SCS in the Treatment of Diabetic Peripheral Neuropathic Pain
NCT06158529Painful Diabetic Peripheral Neuropathy
Fan BiFa
Not applicable
1
Beijing
2025-01-06
Not yet open
TF-antigen Targeting Molecular Probe for PET Imaging in Solid Tumors
NCT06755086Solid Tumors
Peking University Cancer Hospital & Institute
Observational
20
Beijing
2025-01-06
Active, closed
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
NCT06760637Breast Cancer
DrugsPF-07220060·Ribociclib·Abemaciclib·Palbociclib
Pfizer
Phase 3
1,035
Hefei, Beijing, Fuzhou, Foshan, Guangzhou, Nanning, Harbin, Wuhan
2025-01-06
Not yet open
Oseltamivir and Baloxavir Marboxil for Prophylaxis Against Influenza Under a Hospital-based Setting
NCT06762587Influenza, Influenza Prophylaxis, Nosocomial Infection
DrugsOseltamivir·Baloxavir Marboxil
Capital Medical University
Not applicable
372
Beijing
2025-01-05
Recruiting
Safety and Pharmacokinetics of Y-4 Tablets in Healthy Subjects
NCT06935682Healthy Adult Male and Female Volunteers
DrugY-4 tables
Beijing Tiantan Hospital
Phase 1
36
Beijing
2025-01-04
Recruiting
Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese Patients
NCT07036172Obesity Control
DrugWegovy
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 3
460
Beijing
2025-01-03
Recruiting
Endoscopic and Robotic NSM with Immediate Prosthesis Breast Reconstruction
NCT06748677Nipple-sparing Mastectomy, Immediate Prosthesis Reconstruction, Endoscopic Surgery, Robotic Surgery
Peking University People's Hospital
Observational
484
Beijing
2025-01-03
Recruiting
Multi-Reader Multi-Case Trial Evaluating Computer-Aided Tool for Prognostic Prediction of Colorectal Liver Metastases
NCT07027605Colorectal Liver Metastasis (CRLM)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
166
Beijing
2025-01-01
Not yet open
Protective Effect of Angong Niuhuang Against Negative Inflammatory Response and Neurologic Dysfunction After Cardiovascular Surgery
NCT06723366Cardio-pulmonary Bypass, Cardiovascular Surgery, Cerebral Protection, Brain Injury
Nanjing Medical University
Not applicable
120
Beijing, Nanjing
2025-01-01
By invitation
A Study Comparing the Differences Between Young and Non-young Breast Cancer
NCT06793306Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
3,000
Beijing
2025-01-01
Recruiting
Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder
NCT06692361Major Depressive Disorder (MDD), Depression - Major Depressive Disorder
DrugsFMT·Escitalopram
Gang Wang
Not applicable
214
Wuhu, Beijing, Guangzhou, Shijiazhuang, Jining, Chengdu, Tianjin, Dali
2025-01-01
Not yet open
The Diagnostic Value of Bronchoscopic Needle-based Confocal Laser Endomicroscopy (nCLE) As a Real-time Detection Tool for Diagnosing Peripheral Lung Cancer: a Multi-centre Randomised Controlled Trial
NCT06739421Lung Cancer, Non-Small Cell, Lung Cancer, Small Cell
China-Japan Friendship Hospital
Not applicable
1,040
Beijing
2025-01-01
Not yet open
Confocal Laser Endomicroscopy Assisted Endobronchial Ultrasound-guided- Transbronchial Mediastinal Cryobiopsy Via a Tunnel for Diagnosing Mediastinal Lymphadenopathy
NCT06741852Mediastinal Lymphadenopathy
China-Japan Friendship Hospital
Not applicable
98
Beijing
2025-01-01
Recruiting
Al18F-HER2-BCH PET in Breast Patients Treated With ADC Therapy
NCT06909604Breast Cancer
Peking University Cancer Hospital & Institute
Not applicable
50
Beijing
2025-01-01
Not yet open
The New Clinical Registration Trial of Interventional Treatment for Patients with Symptomatic Intracranial Artery Stenosis
NCT06740513Intracranial Atherosclerotic Stenosis (ICAS), Stroke
Xuanwu Hospital, Beijing
Observational
1,000
Beijing
2025-01-01
Recruiting
Bariatric Surgery Combined With GLP-1RA: A Multicenter Study.
NCT07732738Obesity
China-Japan Friendship Hospital
Not applicable
400
Xingtai, Zhengzhou, Baotou, Jinan, Datong, Kunming, Beijing
2025-01-01
Recruiting
Vitreous Zonule in Primary Angle-Closure Glaucoma
NCT07523139Primary Angle-Closure Glaucoma
Peking University People's Hospital
Observational
440
Beijing
2025-01-01
Not yet open
CD147 Targeting Peptide Probe for PET Imaging in Solid Tumors
NCT06720298Solid Tumor
Drug18F-FDG
Peking University Cancer Hospital & Institute
Observational
30
Beijing
2025-01-01
Recruiting
HOPE From the Cerebellum: TMS-Induced Cognitive Recovery After Stroke
NCT06316557Post-stroke Cognitive Impairment, Ischemic Stroke
Zi-Xiao Li
Not applicable
70
Beijing
2025-01-01
Not yet open
Dual-function Semirigid Thoracoscopy Versus Semirigid Thoracoscopy for the Diagnosis of Pleural Diseases: A Multicenter Open-label Randomized Controlled Trial
NCT06744725Pleural Diseases
China-Japan Friendship Hospital
Not applicable
334
Beijing
2025-01-01
Recruiting
A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in Small Cell Lung Cancer
NCT07026669Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
40
Beijing
2025-01-01
Active, closed
Study on the Correlation Between Intraoperative Hypotension and Postoperative Myocardial Injury
NCT07094321Myocardial Injury After Noncardiac Surgery (MINS), Hypotension During Surgery
China-Japan Friendship Hospital
Observational
8,000
Beijing
2025-01-01
By invitation
Protective Effect of Probacine Against Negative Gut Metabolism and Organ Dysfunction After Cardiovascular Surgery (PANDA IV)
NCT04444362Cardiovascular Disease, Cardiopulmonary Bypass
Nanjing Medical University
Not applicable
500
Beijing, Guangzhou, Nanjing, Chengdu, Shanghai
2025-01-01
By invitation
Adaptive Blood Purification for the Treatment of Patients With Septic Shock
NCT06692036Septic Shock
Beijing Chao Yang Hospital
Not applicable
276
Beijing
2025-01-01
Active, closed
RT for Adenocarcinoma/Adenosquamous Carcinoma
NCT07153952Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Radiotherapy
Peking Union Medical College Hospital
Phase 1/2
60
Beijing
2025-01-01
Recruiting
Study Safety and Efficacy of Deep Brain Stimulation (DBS) and Cervical Deep Lymphoid-venous Anastomosis (LVA) in Alzheimer's Disease
NCT07094438Alzheimer Disease
Chinese PLA General Hospital
Phase 1
98
Beijing
2025-01-01
Not yet open
Protective Effect of PCSK9 Inhibitor Against Negative Inflammatory Response and Organ Dysfunction After Coronary Artery Bypass Grafting (PANDA VIII)
NCT06730802Myocardial Ischaemic Syndrome, Coronary Heart Disease
DrugEvolocumab
Nanjing Medical University
Not applicable
400
Beijing, Nanjing
2025-01-01
Recruiting
Multi-Modality Imaging Standard Cohort Of Cerebrovascular Disease
NCT06925178Cerebrovascular Disease
Beijing Tiantan Hospital
Observational
800
Beijing
2025-01-01
Recruiting
Risk Prediction of Disease Progression in Early-Onset Coronary Atherosclerosis
NCT07316452Coronary Disease, Young Adult
Fu Wai Hospital, Beijing, China
Observational
10,000
Beijing
2025-01-01
Recruiting
Mechanism Study of Yangyin Roujin Formula in the Treatment of Fibromyalgia Syndrome
NCT07736144Fibromyalgia Syndrome
Juan Jiao
Not applicable
60
Beijing
2025-01-01
Recruiting
MMP14(MT1-MMP) Targeting Bicyclic Peptide Probe for PET Imaging in Solid Tumors
NCT06719856Solid Tumor
Drug18-FDG
Peking University Cancer Hospital & Institute
Observational
30
Beijing
2025-01-01
Recruiting
Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer
NCT07057102Non Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
40
Beijing
2025-01-01
Not yet open
Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer
NCT06745219Thrombopenia, Cervical Cancer, Radiotherapy Side Effect, Chemotherapeutic Toxicity
Peking University Cancer Hospital & Institute
Phase 2
30
Beijing
2025-01-01
Not yet open
Study of MT027 in Patients with Brain, Meninges, and Spinal Cord Metastatic Solid Tumors
NCT06742593Brain (Nervous System) Cancers, Brain and Central Nervous System Tumors, Brain Tumors
Suzhou Maximum Bio-tech Co., Ltd.
Phase 1
12
Beijing
2025-01-01
Recruiting
TACE Combined Surgery for the Resectable Huge HCC
NCT06898398Hepatocellular Carcinoma, Hepatic Chemotherapy, Liver Cancer, Surgery
Sun Yat-sen University
Observational
326
Beijing
2025-01-01
Recruiting
Zanubrutinib Combined With G-CVP in Previously Untreated FL
NCT06959732Follicular Lymphoma ( FL)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
40
Beijing
2025-01-01
Recruiting
Glycemic Improvement With Team, Technology, Education and Peer Resources in Type 1 Diabetes-GLITTER Study
NCT07097805Type 1 Diabetes (T1D)
Second Xiangya Hospital of Central South University
Not applicable
3,000
Beijing, Guangzhou, Shenzhen, Luoyang, Changsha, Nanjing, Shenyang, Chengdu
2025-01-01
Active, closed
The Exploration of OX40 (CD134) Expression Levels in Sarcoma Specimens and Its Clinical Application in Prognosis Determination
NCT06751251Sarcoma, Biomarkers, Progression
Peking University People's Hospital
Observational
200
Beijing
2025-01-01
Recruiting
Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial
NCT07101588Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Chinese PLA General Hospital
Phase 4
200
Beijing
2025-01-01
Recruiting
Early Vitrectomy vs PRP in Early Proliferative Diabetic Retinopathy
NCT07586787Proliferative Diabetic Retinopathy (PDR)
Xiamen Ophthalmology Center Affiliated to Xiamen University
Not applicable
100
Beijing, Xiamen, Zhengzhou, Nanjing, Dalian
2025-01-01
Recruiting
Remimazolam and Emergence Delirium in Pediatrics
NCT07046364Pediatric, Neurosurgery, Sevoflurane Anesthesia, Remimazolam
DrugRemimazolam
Peking University First Hospital
Phase 4
248
Beijing
2025-01-01
Recruiting
Rectal Cancer Neoadjuvant Therapy-Real World Study
NCT07566559Rectal Cancer
Beijing Friendship Hospital
Observational
869
Beijing
2025-01-01
Not yet open
Prospective Cohort Study on Predicting the Progression of Diabetic Microangiopathy Using Multimodal Eye Imaging
NCT06727955Diabetic Retinopathy
Peking University Third Hospital
Observational
250
Beijing
2025-01-01
Recruiting
AI in Predicting Polyp Pathology and Endoscopic Classification
NCT06773832Colorectal Polyps
Peking Union Medical College Hospital
Observational
400
Beijing
2025-01
Rows per page Showing 2701–2800 of 5484
Previous 26 27 28 29 30 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing?page=28

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 5,484 of those studies with a site in Beijing.

How many clinical trials are recruiting in Beijing?

3,341 of the 5,484 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 966 have not yet opened recruitment, 1,001 are active but closed to new participants, and 176 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.